Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange ...

Aversa Fentanyl holds the potential to become the world’s first abuse-deterrent opioid patch.

AVERSA Fentanyl has the potential to be the world’s first abuse-deterrent opioid patch designed to deter the abuse and misuse and reduce the risk of accidental exposure of transdermal fentanyl ...

Nutriband Inc. has announced an exclusive partnership with Kindeva Drug Delivery to develop Aversa™ Fentanyl, which combines Nutriband's abuse-deterrent technology with Kindeva's FDA-approved ...

We are primarily engaged in the development of a portfolio of transdermal pharmaceutical products. Our lead product under development is an abuse-deterrent fentanyl patch incorporating our AVERSA™ ...

Identity Dental Marketing proudly celebrates 15 years of providing innovative and custom marketing solutions that help dental practices thrive in a competitive landscape. Founded by Grace Rizza, CEO ...

Curing Stomach Cancer (DDF) is proud to announce its sponsorship of a Scholar-in-Training Award (SITA) at the 116th Annual Meeting of the American Association for Cancer Research (AACR), taking place ...

ORLANDO - Nutriband Inc. (NASDAQ:NTRB), a developer of transdermal pharmaceutical products, has announced an exclusive partnership with Kindeva Drug Delivery to develop Aversa™ Fentanyl, a potential ...